Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Employee Benefits Health Trust topic

No spam. Unsubscribe anytime.

Meridian council asks trust to run market "pulse check" after proposed 17% health-plan jump

3410461 · May 21, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Council discussed the city’s partially self-funded employee health benefits trust, heard that the proposed rate increase for the coming year is about 17%, and directed staff and trust leaders to pursue a market “pulse check,” review legal/procurement constraints and return with recommendations in two weeks.

The Meridian City Council discussed the city’s employee health benefits plan and asked staff and the health trust to seek a market “pulse check” of vendors and return with recommendations in roughly two weeks.

The council heard from City Attorney Bill Neri, who explained that Meridian’s plan is a partially self-funded trust that is evaluated more on vendor services and administrative arrangements than a single fixed premium. “So with marketing, then we’re looking at really the service side,” Neri said, and described a pulse check as a common, nonbinding market review for self-funded plans.

Why it matters: Council members pressed for clarity because the plan shows a proposed roughly 17% increase for the coming year after a 0% increase last year. Finance staff told the council they normally expect roughly 8% annual inflation for health costs; the larger uptick this year reflects claims experience and reduced reserve cushions. Council members emphasized both employee continuity and fiscal stewardship.

Neri and trust members explained trade-offs. He said a market-driven savings number such as 5% can be relevant, “but it’s not the sole driver,” and cautioned that network differences, card numbers, billing systems and provider relationships can cause disruption when a plan switches carriers. He described benefits the trust has gotten from an ongoing relationship with Blue Cross, including expedited implementation and quicker dispute resolution.

Council members asked several technical questions. Councilman Taylor asked whether recent higher use of GLP-type medications could be contributing to rising costs: “kinda curious if you know if the sort of explosion of the use of GLP drugs has over the last year to 2 years … has that been part of what we’ve seen in this big jump?” Neri said he had not yet seen GLP prescribing show up as a primary cost driver in the city’s claim list but would raise the question at the trust meeting scheduled the next day.

Other cost drivers discussed included high-cost biologic drugs (Neri and trust staff identified HUMIRA and similar biologics and noted work to add biosimilars), cancer and cardiovascular claims and unpredictable large claims (for example, neonatal intensive care). Trust representatives said preventive care and primary-care engagement remain the most effective long-term cost-control strategies.

Council members also asked about the procurement process for a self-funded trust. Neri and HR staff said a full procurement-style RFP is not typically required for the trust; instead staff run a market pulse check every three to five years for self-funded plans and evaluate service offerings (administration, stop-loss, networks). HR clarified the pulse-check cadence as every three to five years; Neri added legal and Department of Insurance considerations could affect whether the trust uses the city’s formal purchasing process.

Action and next steps: Council vice president Elizabeth Strader summarized the direction she heard and listed action items: staff will check legal constraints, consult procurement, engage trust leadership and bring a recommendation back—through the trust—to the council in about two weeks. Neri said the trust would evaluate service providers and present contract-level options and cost/impact trade-offs. Council members asked the trust to prioritize (1) preserving employee service and access, and (2) taxpayer value, and to report on high-cost drug spend (including GLP-class medicines) if data permit.

Quotes from participants: “A pulse check is a very common practice for these types of self-funded plans,” Bill Neri told the council. Councilman Taylor asked trust staff to detail whether newer drug classes have affected claims: “I think it would be interesting to know, if you have the aggregate data, how much we spent this last year on that versus previous.”

Ending: Trust staff said rate renewals and detailed claim reports will be explored at the trust’s next meeting and brought to council as part of the update; staff requested council feedback within two weeks on legal and procurement questions so a recommended path (pulse check vs. formal procurement) can be returned to the council on the stated schedule.